Categories: News

123Invent Inventor Develops Modified Glasses to Assist with Reading (BRA-8028)

PITTSBURGH , July 24, 2025 /PRNewswire/ — “I wanted to create reading glasses like to no other to help with reading,” said an inventor, from Austalind, WA, Australia, “so I invented the EASY READ. My design could help solve reading problems for anyone who has trouble reading, and it could help you follow along or focus while reading.”

The invention provides a modified pair of reading glasses to assist with reading. In doing so,

it helps the user hear or sound out words and sentences while reading. As a result, it reduces the need for help. It also could help the user follow along or concentrate while reading. The invention features an innovative design that is easy to use so it is ideal for all ages, individuals having trouble reading or learning to read, blind or visually impaired individuals, etc.

EASY READ is currently available for licensing or sale to manufacturers or marketers. For more information, visit www.myeasyread.net. Or contact Shenton Cunningham at 041-192-3224 or email info@myeasyread.net.

View original content to download multimedia:https://www.prnewswire.com/news-releases/123invent-inventor-develops-modified-glasses-to-assist-with-reading-bra-8028-302512122.html

SOURCE InventHelp

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

3 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

5 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

5 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

5 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

5 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

5 hours ago